Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. - Wikidata - wikimedia - TriplyDB

Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke.

Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke.

http://www.wikidata.org/entity/Q48485705

about

Thrombolysis for acute ischaemic stroke Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke Thrombolysis for acute ischaemic stroke Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke Thrombolysis for acute ischaemic stroke Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis Mechanical Thrombectomy Is Now the Gold Standard for Acute Ischemic Stroke: Implications for Routine Clinical Practice Combined neurothrombectomy or thrombolysis with adjunctive delivery of 3K3A-activated protein C in acute ischemic stroke Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials Reperfusion therapy of acute ischaemic stroke and acute myocardial infarction: similarities and differences Revascularization grading in endovascular acute ischemic stroke therapy Treatment Strategies for Acute Ischemic Stroke Caused by Carotid Artery Occlusion Catheter-based interventions for acute ischaemic stroke Ischaemic stroke and ST-segment elevation myocardial infarction: fast-track single-stop approach Therapy for early reperfusion after stroke Review article: Why is there still a debate regarding the safety and efficacy of intravenous thrombolysis in the management of presumed acute ischaemic stroke? A systematic review and meta-analysis.Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement.Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke Formation of a Liquid Jet by Interaction between a Laser-induced Bubble and a Shock Wave.Intra-arterial versus intra-venous thrombolysis within and after the first 3 hours of stroke onset Safety and efficacy of 0.6 mg/kg rt-PA: optimum rt-PA dose revisited.Enhancement of fibrinolytics with a laser-induced liquid jet.Imaging of acute stroke prior to treatment: current practice and evolving techniques.Equipoise among recanalization strategies.Endovascular treatment for acute ischemic stroke patients: implications and interpretation of IMS III, MR RESCUE, and SYNTHESIS EXPANSION trials: A report from the Working Group of International Congress of Interventional Neurology Intra-arterial thrombolysis in acute ischaemic stroke: experience with a superselective catheter embedded in the clot.Cerebral collateral circulation in carotid artery disease.Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis.Thrombolytic therapy for stroke: a review with particular reference to elderly patients.Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke.A neuroprotective mechanism of YGY-E in cerebral ischemic injury in rats.Factors affecting the apparent efficacy and safety of tissue plasminogen activator in thrombotic occlusion models of stroke: systematic review and meta-analysis Fibrinolysis and Beyond: Bridging the Gap between Local and Systemic Clot Removal.Determinants of early outcomes in patients with acute ischemic stroke and proximal artery occlusion Methodology of the Interventional Management of Stroke III Trial.Superselective Intra-arterial Thrombolysis for Acute Cardioembolic Stroke in a Child with Idiopathic Dilated Cardiomyopathy. A Case Report.Comparison of susceptibility weighted imaging and TOF-angiography for the detection of Thrombi in acute stroke.Observer reliability of CT angiography in the assessment of acute ischaemic stroke: data from the Third International Stroke Trial Influence of racial differences on outcomes after thrombolytic therapy in acute ischemic stroke.Thrombolysis for acute ischaemic stroke: core nursing requirements.

P2860

Q24194788-3D767EDF-838D-43FB-88EE-B4AA26D6CF34 Q24202641-0F75F363-8A7C-48C8-97AE-EF77F21F7326 Q24240067-2F919E1E-6FB8-4E8C-ABA3-1A87C1A22B45 Q24245758-C16061B0-E19D-413F-A8BA-9674DBEC463B Q24247962-CE917733-159F-42AB-A171-3DB22CFFE793 Q24595703-98199582-12B3-4A8A-BD87-4ECC38F8D3E0 Q26776269-46697542-39F7-4442-BEFA-5DFDBB03F55F Q26782990-7E03159D-5F10-4D28-8391-F87028BCFD19 Q26823902-D3ABAAE4-E6B1-4890-9E89-0F81BF5BC408 Q26824552-19D39C0F-9886-4819-BB33-E903001C336F Q27026934-80197E1B-B45D-493F-94F1-1B50D187A1FF Q28076918-44283AAB-9D5F-4A19-9C70-C078D490EEB0 Q28079525-EA476449-A245-4D4C-99C1-04088B9BB321 Q28082597-36251EA8-F210-43C2-8580-7834EE1364AA Q28210949-136241A9-8B2D-40C4-9A83-F24C391950B0 Q30248290-FA06EB3D-8361-444A-9DB3-83BC8C99866C Q30410761-6AC921B5-A929-48F0-AA6B-E437A7BFCC46 Q30414441-C4B78500-B755-444C-899E-759C33AFB143 Q30455435-12BA94B0-8B77-4A64-B649-8C96FF8335A6 Q30470195-8733C274-C949-4548-96C8-BEC7DE77737C Q30568978-A2503925-D5EE-4042-8851-F154E9392B57 Q30779406-79F31094-44C9-465D-8B30-9B801F463803 Q30831710-220FDCC8-C1CD-4A31-A2BF-7CA55730BC73 Q33547270-B3B47816-EE92-49DA-B37D-86EAAD3989F0 Q33735191-C119459F-E255-460A-A95E-D57F3D13D7DA Q33735356-64D5E953-1FE9-45ED-9487-D204FAF0EB26 Q33743870-298F46EB-0390-419E-9819-5B7F28C5EC10 Q33785353-15E67379-5749-4B0F-BBC8-97BE767570F9 Q33873285-E59A33BE-D1AE-4529-AC8E-91EB187FD3B0 Q33908058-A7D2D0EA-33D7-4F3C-B2C7-7666D2E552CE Q34142010-EAC1EA73-C9B5-45DC-86C1-ED01B2FCA9D4 Q34410346-84BDA618-D6B1-4248-A840-3DDCF3C54F80 Q34603396-E923D3D8-5944-4BC5-91A3-F5E565BF87B6 Q34633118-0D27EA1A-5607-473B-B27B-22E45645EA51 Q34672825-4031490F-2163-4F65-B3DE-C903117613F0 Q34719938-0839D933-2F69-447C-806D-E8D5B969978C Q34744120-3EC58776-5D17-495C-B1B4-0AEDA4770398 Q34965049-5E67596F-DAEF-4243-A5E4-DC4DBF786EAF Q35024112-329C5D7B-67AC-4A3E-85DE-C922C4DAAD98 Q35126046-2F5DBABD-0B59-414B-AFAE-505A26D9026E

P2860

Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke.

http://www.wikidata.org/entity/Q48485705

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年学术文章

@wuu

1992年学术文章

@zh

1992年学术文章

@zh-cn

1992年学术文章

@zh-hans

1992年学术文章

@zh-my

1992年学术文章

@zh-sg

1992年學術文章

@yue

1992年學術文章

@zh-hant

name

Intravenous recombinant tissue ...... rotid artery territory stroke.

@en

Intravenous recombinant tissue ...... rotid artery territory stroke.

@nl

type

label

Intravenous recombinant tissue ...... rotid artery territory stroke.

@en

Intravenous recombinant tissue ...... rotid artery territory stroke.

@nl

prefLabel

Intravenous recombinant tissue ...... rotid artery territory stroke.

@en

Intravenous recombinant tissue ...... rotid artery territory stroke.

@nl

P1433

Q48485705-63FCE5B0-2D04-45A5-8475-3C9A10750456

P1476

Q48485705-96A54E30-D2D3-4499-80E0-8044A64D0D9D

P2093

Q48485705-02C6F638-2ABB-429E-97C4-32D195755BF2

Q48485705-04149BEF-17F5-44D5-B383-89E9E63AA482

Q48485705-05146BEE-4B54-457F-82C0-D87C5D4ED98D

Q48485705-0A5264B2-9E78-4AFC-9103-2F7DF712074C

Q48485705-1B5F7EFF-01CD-45A2-832F-7347933E6A51

Q48485705-59F0C61E-F20E-485A-AB8A-F982EECA7377

Q48485705-5B89DC56-8303-499C-81E3-6654842055E4

Q48485705-891323F2-A555-4054-B436-ABF400C412B1

Q48485705-8C4054CB-3D29-4771-86AF-D191E925A7FE

P304

Q48485705-143335F1-BF7E-4C44-8C89-67E720A19102

P31

Q48485705-58A8BF4D-276D-4349-9B20-7E03C7348FE8

P356

Q48485705-935AA944-7A9B-4FF6-B3A5-7E43D59BC6BF

P407

Q48485705-62E7DA07-55E6-40EF-93F4-664785DD33F9

P433

Q48485705-17527173-3F4F-47B9-B3E0-C0D8F9FA3513

P478

Q48485705-25BBD8BC-D4B1-4BF2-BEA4-765F6C962413

P577

Q48485705-C8B8DF79-CB0F-44C3-A3AE-D890BC8A0A7F

P698

Q48485705-FE7C2054-5819-4636-8D4D-BED6D85C83BD

P356

P1433

P1476

Intravenous recombinant tissue ...... rotid artery territory stroke.

@en

P2093

Kitano K

http://www.w3.org/2001/XMLSchema#string

Mori E

http://www.w3.org/2001/XMLSchema#string

Ohkawa S

http://www.w3.org/2001/XMLSchema#string

Ohsumi Y

http://www.w3.org/2001/XMLSchema#string

Tabuchi M

http://www.w3.org/2001/XMLSchema#string

Tsutsumi A

http://www.w3.org/2001/XMLSchema#string

Yamadori A

http://www.w3.org/2001/XMLSchema#string

Yoneda Y

http://www.w3.org/2001/XMLSchema#string

Yoshida T

http://www.w3.org/2001/XMLSchema#string

P304

976-982

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.42.5.976

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

1992-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1579252

http://www.w3.org/2001/XMLSchema#string